{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:45:25Z","timestamp":1776872725404,"version":"3.51.2"},"reference-count":31,"publisher":"Baishideng Publishing Group Inc.","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Hepatol"],"abstract":"<jats:p>BACKGROUND<\/jats:p>\n          <jats:p>T helper 17 (Th17) cell infiltration and interleukin (IL)-17 secretion in intrahepatic small bile ducts is a critical driver of immune-mediated injury in primary biliary cholangitis (PBC). IL-6 is an essential upstream activator of Th17 cells. Basophil-derived IL-6 promotes the differentiation of CD4+ T cells and Th1 cells into Th17 cells, thereby regulating their immunological functions.<\/jats:p>\n          <jats:p>AIM<\/jats:p>\n          <jats:p>To investigate the activation status and cytokine expression of basophils in PBC, elucidating potential mechanisms through which basophils contribute to its pathogenesis.<\/jats:p>\n          <jats:p>METHODS<\/jats:p>\n          <jats:p>This single-center retrospective case-control study conducted at Guangdong Medical University Affiliated Hospital (China) between September 2019 and August 2024 enrolled 65 consecutive treatment-na\u00efve patients with PBC (PBC group), 65 age- and sex-matched patients with chronic hepatitis B (CHB group), and 65 healthy controls (Normal group). Fourteen participants per group (subgroup) were randomly selected for flow cytometry analysis of basophil proportion, activation markers (CD203c and CD62 L mean fluorescence intensity), IL-6-positive basophils (IL-6+ basophils as a percentage of total basophils), and IL-17-positive T lymphocytes (CD3+CD4+IL-17+ cells) proportion among T cells. Data were analyzed using Kruskal-Wallis and \u03c7 2 tests as appropriate.<\/jats:p>\n          <jats:p>RESULTS<\/jats:p>\n          <jats:p>Routine blood tests revealed significantly higher basophil counts and proportions in the PBC group compared to the CHB and Normal groups (P  &lt; 0.001 for both comparisons), with no significant differences between the CHB and Normal groups (P  = 0.201). Flow cytometry revealed a higher basophil proportion in the PBC subgroup compared to the CHB (P  = 0.011) and Normal subgroups (P  &lt; 0.001). The mean fluorescence intensity of CD203c on basophil surfaces was elevated in the PBC subgroup compared to the CHB (P  = 0.032) and Normal subgroups (P  = 0.039). The proportion of IL-6+ basophils was significantly higher in the PBC subgroup than in the CHB (P  &lt; 0.01) and Normal subgroups (P  &lt; 0.001). Similarly, the Th17 cell proportion was markedly elevated in the PBC compared to the CHB (P  &lt; 0.001) and Normal subgroups (P  &lt; 0.001).<\/jats:p>\n          <jats:p>CONCLUSION<\/jats:p>\n          <jats:p>Patients with PBC have increased peripheral basophil counts with enhanced activation. Activated basophils have increased IL-6 expression, which may indirectly induce Th17 cell proliferation and contribute to PBC pathogenesis.<\/jats:p>","DOI":"10.4254\/wjh.v17.i8.109685","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T01:18:48Z","timestamp":1756257528000},"source":"Crossref","is-referenced-by-count":1,"title":["Peripheral basophil activation: A hidden player in the immunopathogenesis of primary biliary cholangitis"],"prefix":"10.4254","volume":"17","author":[{"given":"Huan-Qin","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Min","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Qiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31607-X"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15329"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01303-5"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32117"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2025.0953"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2018.05.008"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00154-3"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001225"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09044-5"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.022"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26979"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2008.11.001"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.07.100"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.07.005"},{"key":"B15","unstructured":"Guggino G, Giardina AR, Raimondo S, Giardina G, Sireci G, Dieli F, Peralta M, Alessandro R, Triolo G, Ciccia F. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion. Clin Exp Rheumatol 2014; 77-81"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056595"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature04753"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.02.007"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm045"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070663"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15417"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2312"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02041-1"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2014.899010"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/srep41744"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10276-6"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2023.00320"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2006.12.002"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1159\/000077351"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.20526"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/imr.70024"}],"container-title":["World Journal of Hepatology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i8\/109685.htm","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i8\/109685.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T01:19:45Z","timestamp":1756257585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1948-5182\/full\/v17\/i8\/109685.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":31,"journal-issue":{"issue":"8"},"alternative-id":["109685"],"URL":"https:\/\/doi.org\/10.4254\/wjh.v17.i8.109685","relation":{},"ISSN":["1948-5182"],"issn-type":[{"value":"1948-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}